Skip to main content
. Author manuscript; available in PMC: 2010 Jul 20.
Published in final edited form as: Neuropsychopharmacology. 2006 Nov 8;32(5):1098–1108. doi: 10.1038/sj.npp.1301228

Table 1.

Schematic Representation of Experimental Procedures

Training phase
Group Lever Lever training NIC SA 30 NIC Baseline Extinction Reacquisition
2-Lever VS Food VS VS VS VS
30 NIC (n=9) SAL/SAL (n=9)
Infusion Food 60 NIC (n=8) 30 NIC SAL/30 NIC
90 NIC (n=7) MEC/30 NIC (n=8)
NIC+VS 30 NIC+VS (n=6) SAL/SAL+VS (n=8)
Active Food 60 NIC+VS (n=8) 30 NIC+VS SAL/30 NIC+VS
90 NIC+VS (n=6) MEC/30 NIC+VS (n=10)
Inactive Food
NIC-Only 30 NIC+VS (n=8) SAL/SAL (n=10)
Active Food 60 NIC+VS (n=6) 30 NIC+VS SAL/30 NIC
90 NIC+VS (n=8) MEC/30 NIC (n=9)
Inactive Food
VS-Only VS Food VS VS VS VS
Infusion Food SAL (n=6) SAL SAL/SAL (n=3) SAL/SAL
MEC/SAL (n=3)

NIC, /NIC: nicotine infusions available during session; SAL, /SAL: vehicle infusions available during session; VS: visual stimulus; 30, 60, 90: unit nicotine dose (μg/kg/infusion); MEC/, SAL/: mecamylamine or vehicle pretreatment 15min before session; (n=x): number of subjects included in analyses for NIC SA and Baseline–Extinction–Reacquisition phases, chloral hydrate tests determined catheter patency after NIC SA and Reacquisition phases.